- Home
- DSM vs SMLR Comparison
DSM vs SMLR Comparison
Compare DSM & SMLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSM
- SMLR
- Stock Information
- Founded
- DSM 1989
- SMLR 2007
- Country
- DSM United States
- SMLR United States
- Employees
- DSM N/A
- SMLR N/A
- Industry
- DSM Investment Managers
- SMLR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DSM Finance
- SMLR Health Care
- Exchange
- DSM Nasdaq
- SMLR Nasdaq
- Market Cap
- DSM 303.5M
- SMLR 289.5M
- IPO Year
- DSM N/A
- SMLR 2014
- Fundamental
- Price
- DSM $6.12
- SMLR $61.75
- Analyst Decision
- DSM
- SMLR
- Analyst Count
- DSM 0
- SMLR 0
- Target Price
- DSM N/A
- SMLR N/A
- AVG Volume (30 Days)
- DSM 161.7K
- SMLR 1.1M
- Earning Date
- DSM 01-01-0001
- SMLR 11-04-2024
- Dividend Yield
- DSM 3.97%
- SMLR N/A
- EPS Growth
- DSM N/A
- SMLR N/A
- EPS
- DSM N/A
- SMLR 2.04
- Revenue
- DSM N/A
- SMLR $58,938,000.00
- Revenue This Year
- DSM N/A
- SMLR N/A
- Revenue Next Year
- DSM N/A
- SMLR N/A
- P/E Ratio
- DSM N/A
- SMLR $30.30
- Revenue Growth
- DSM N/A
- SMLR N/A
- 52 Week Low
- DSM $4.69
- SMLR $20.88
- 52 Week High
- DSM $6.05
- SMLR $79.45
- Technical
- Relative Strength Index (RSI)
- DSM 55.38
- SMLR 61.11
- Support Level
- DSM $6.09
- SMLR $57.33
- Resistance Level
- DSM $6.18
- SMLR $69.67
- Average True Range (ATR)
- DSM 0.05
- SMLR 9.09
- MACD
- DSM 0.02
- SMLR -0.32
- Stochastic Oscillator
- DSM 73.91
- SMLR 51.22
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.
About SMLR Semler Scientific Inc.
Semler Scientific Inc is a United States based company that is engaged in providing technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. It focuses on developing, manufacturing, and marketing proprietary products and services that assist customers, including insurance plans, physicians, and risk assessment groups, in evaluating and treating chronic diseases. The company markets its vascular-testing product under the QuantaFlo brand, which is a four-minute in-office blood flow test.